{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:27:26Z","timestamp":1784082446173,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002269","name":"Pacific Vision Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102282","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:26:16Z","timestamp":1739906776000},"page":"102282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Spectral-domain optical coherence tomography imaging findings in patients receiving teprotumumab for thyroid eye disease"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-2653","authenticated-orcid":false,"given":"Timothy","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-4107","authenticated-orcid":false,"given":"Rona Z.","family":"Silkiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnell Renz","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan V.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Eliasieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse J.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajoc.2025.102282_bib1","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ajoc.2025.102282_bib2","article-title":"Orbital lymphocyte populations in three states of thyroid eye disease","volume":"31","author":"Griffin","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102282_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/ICU.0b013e3283499446","article-title":"The pathophysiology of thyroid eye disease: implications for immunotherapy","volume":"22","author":"Douglas","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102282_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2025.102282_bib5","article-title":"Horizon Therapeutics. Tepezza (teprotumumab) [package insert]","year":"2020","journal-title":"U.S. Food and Drug Administration website"},{"issue":"18","key":"10.1016\/j.ajoc.2025.102282_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102282_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/01945998211004240","article-title":"Thyroid eye disease, teprotumumab, and hearing loss: an evolving role for otolaryngologists","volume":"165","author":"Chern","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102282_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-248335","article-title":"Teprotumumab-associated chronic hearing loss screening and proposed treatments","volume":"15","author":"Chow","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102282_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MAO.0000000000003428","article-title":"Sensorineural hearing loss after teprotumumab therapy for thyroid eye disease: a case report","volume":"43","author":"Ding","year":"2022","journal-title":"Otol Neurotol"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102282_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/00034894211042740","article-title":"Ototoxicity and teprotumumab","volume":"131","author":"Highland","year":"2022","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ajoc.2025.102282_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2022.02.015","article-title":"Hearing dysfunction after treatment with teprotumumab for thyroid eye disease","volume":"240","author":"Sears","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102282_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X221097097","article-title":"Audiologic demonstration of ototoxicity from teprotumumab treatment in a patient with thyroid eye disease","volume":"6","author":"Najjar","year":"2022","journal-title":"OTO Open"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102282_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000002078","article-title":"Rifle blast exacerbating hearing loss in a patient treated with teprotumumab for thyroid eye disease","volume":"38","author":"Reed","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2023.08.001","article-title":"Frequency and patterns of hearing dysfunction in patients treated with teprotumumab","volume":"131","author":"Keen","year":"2024","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000002146","article-title":"The role of insulin-like growth factor-1 and its receptor in the eye: a review and implications for IGF-1R inhibition","volume":"39","author":"Truong","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"JUL","key":"10.1016\/j.ajoc.2025.102282_bib16","article-title":"IGF-1, inflammation and retinal degeneration: a close network","volume":"10","author":"Arroba","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102282_bib17","doi-asserted-by":"crossref","DOI":"10.1159\/000365132","article-title":"Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?","volume":"106","author":"Stahl","year":"2014","journal-title":"Neonatology"},{"issue":"10","key":"10.1016\/j.ajoc.2025.102282_bib18","article-title":"Comparative analysis of aqueous humor cytokine levels between patients with exudative age-related macular degeneration and normal controls","volume":"54","author":"Cha","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102282_bib19","article-title":"Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization","volume":"51","author":"Sengupta","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102282_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-021-05336-4","article-title":"Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT","volume":"260","author":"Del Noce","year":"2022","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64925-5","article-title":"Superficial ocular vascular changes after orbital decompression in patients with thyroid ophthalmopathy measured by anterior segment OCT angiography; an observational study","volume":"14","author":"Rafizadeh","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102282_bib22","article-title":"Changes in clinical activity, serum autoantibody levels, and chorioretinal vessels after systemic glucocorticoid therapy in thyroid eye disease","volume":"12","author":"Lee","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib23","article-title":"The changes of retinal nerve fibre layer and ganglion cell layer with different severity of thyroid eye disease","volume":"36","author":"Guo","year":"2022","journal-title":"Eye (Basingstoke)"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102282_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/tjo.TJO-D-22-00110","article-title":"Changes in retinal nerve fiber layer, ganglion cell complex, and ganglion cell layer thickness in thyroid eye disease: a systematic review","volume":"14","author":"Chien","year":"2023","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102282_bib25","article-title":"Assessment of retinal and choroidal vessel density and nerve fiber layer thickness changes after orbitotomy in sever NON- active thyroid orbitopathy patients (A retrospective study)","author":"Tehrani","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65884-7","article-title":"Effect of orbital decompression surgery on the choroidal profile in patients with thyroid eye disease","volume":"14","author":"Rafizadeh","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajoc.2025.102282_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4808194","article-title":"The changes in optic nerve after orbital decompression surgery for thyroid eye disease and case reports of ischemic optic neuropathy","volume":"2022","author":"Hsia","year":"2022","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102282_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153064","article-title":"Macular ganglion cell analysis determined by Cirrus HD optical coherence tomography for early detecting chiasmal compression","volume":"11","author":"Yum","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102282_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/ceo.13525","article-title":"Choroidal thickness in thyroid-associated orbitopathy","volume":"47","author":"Lai","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2025.102282_bib30","article-title":"Shadow removal and contrast enhancement in optical coherence tomography images of the human optic nerve head","volume":"52","author":"Girard","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jes151","article-title":"Imaging of coronary artery plaques using contrast-enhanced optical coherence tomography","volume":"14","author":"Foin","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ajoc.2025.102282_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-022-03375-x","article-title":"Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series","volume":"16","author":"Chu","year":"2022","journal-title":"J Med Case Rep"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102282_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000002049","article-title":"Intraocular pressure and glaucoma in thyroid eye disease","volume":"38","author":"Betzler","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102282_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000002310","article-title":"Associations between thyroid eye disease and glaucoma among those enrolled in the national institutes of Health all of us research program","volume":"39","author":"Delavar","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102282_bib37","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0420.1999.770618.x","article-title":"Ocular pulse amplitude in patients with Graves' disease: a preliminary study","volume":"77","author":"Alimgil","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"9","key":"10.1016\/j.ajoc.2025.102282_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-020-01392-7","article-title":"Retinal, choroidal and optic disc analysis in patients with Graves' disease with or without orbitopathy","volume":"40","author":"Casini","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102282_bib39","article-title":"Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy","volume":"19","author":"Meirovitch","year":"2017","journal-title":"Isr Med Assoc J"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102282_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-022-02339-w","article-title":"Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy","volume":"42","author":"Ogmen","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s40662-020-00180-9","article-title":"Reduced macular inner retinal thickness and microvascular density in the early stage of patients with dysthyroid optic neuropathy","volume":"7","author":"Wu","year":"2020","journal-title":"Eye and Vision"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102282_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/aos.12096","article-title":"Expression of insulin-like growth factor 1 receptor in rat retina following optic nerve injury","volume":"91","author":"Bu","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102282_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.crneur.2022.100068","article-title":"Insulin-like growth factor-1 stimulates retinal cell proliferation via activation of multiple signaling pathways","volume":"4","author":"de Figueiredo","year":"2023","journal-title":"Current Research in Neurobiology"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054462","article-title":"The insulin-like growth factor 1 receptor is essential for axonal regeneration in adult central nervous system neurons","volume":"8","author":"Dupraz","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102282_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05074-3","article-title":"Insulin-like growth factor 1 receptor mediates photoreceptor neuroprotection","volume":"13","author":"Rajala","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajoc.2025.102282_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102282_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2023.07.026","article-title":"Influence of carotid endarterectomy on choroidal perfusion: the INFLATE study","volume":"8","author":"Zhang","year":"2024","journal-title":"Ophthalmol Retina"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:25:52Z","timestamp":1760145952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"alternative-id":["S2451993625000350"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102282","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spectral-domain optical coherence tomography imaging findings in patients receiving teprotumumab for thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102282"}}